跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,414 条关于
“CD20 receptor”
全部
13,414
临床试验
6,510
药物
1,724
机构
30
资讯
5,150
去年
FDA Extends Review of Novartis' Ofatumumab for Multiple Sclerosis
去年
Lyell Immunopharma's IMPT-314 Shows Promise in B-Cell Lymphoma Trial
5个月前
AvenCell Doses First Patient with World's First CRISPR-Engineered Dual-Targeting Allogeneic CAR-T Therapy
9个月前
AvenCell Therapeutics Receives FDA and EMA Clearance for Phase I/II Trial of Dual-Target Allogeneic CAR-T Therapy
去年
Lyell's IMPT-314 CAR T-cell Therapy Shows Promise in B-Cell Lymphoma
去年
Lyell Immunopharma's IMPT-314 Shows Promise in Phase 1-2 Trial for Large B-Cell Lymphoma
去年
COVID-19 Vaccination in Multiple Sclerosis: Balancing Efficacy and Safety
去年
Dual-Targeted CAR-T Therapy KITE-363 Shows 87% Response Rate in Relapsed B-Cell Lymphoma
去年
CD20 Bispecific Antibodies Show Promise in Lymphoma Treatment at ASH
5年前
Bispecific CAR-T Therapy Targeting CD19/CD20 Shows Promise in Relapsed B-Cell Lymphoma
第 1 页,共 515 页
上一页
下一页